Sacrocolpopexy for Pelvic Organ Prolapse: Nothing Lasts Forever . . .

Initial results of the Colpopexy and Urinary Reduction Efforts (CARE) trial (JW Womens Health 2006 Jun 6) showed that, at 2 years, open abdominal sacrocolpopexy for pelvic organ prolapse plus concomitant urethropexy significantly reduced risk for postoperative stress urinary incontinence and resulted in a 95% cure rate for vaginal prolapse. Now, in the extended CARE study, investigators evaluated 126 women (39% of the original cohort) for recurrent prolapse, urinary incontinence, or both 7 years after pelvic organ prolapse surgery with or without urethropexy.

Failure rates gradually rose during follow-up. At 7 years, the composite probability of recurrent pelvic organ prolapse (based on anatomic plus symptomatic criteria) was 0.48 with ureth…